132 related articles for article (PubMed ID: 32882665)
1. Expression of IFN-induced 2'-5'-oligoadenylate synthetases correlates with immune infiltration, revealing potential targets and new biomarkers for basal-like breast cancer prognosis.
Zhao J; Zhang X; Cheng M; Guan J; Gai J; Fu L; Zhang R; Du T; Li Q
Int Immunopharmacol; 2020 Nov; 88():106916. PubMed ID: 32882665
[TBL] [Abstract][Full Text] [Related]
2. Origin and development of oligoadenylate synthetase immune system.
Hu J; Wang X; Xing Y; Rong E; Ning M; Smith J; Huang Y
BMC Evol Biol; 2018 Dec; 18(1):201. PubMed ID: 30587119
[TBL] [Abstract][Full Text] [Related]
3. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer.
Zhang Y; Yu C
BMC Cancer; 2020 Jun; 20(1):575. PubMed ID: 32560641
[TBL] [Abstract][Full Text] [Related]
4. Enzymatically active 2',5'-oligoadenylate synthetases are widely distributed among Metazoa, including protostome lineage.
Päri M; Kuusksalu A; Lopp A; Kjaer KH; Justesen J; Kelve M
Biochimie; 2014 Feb; 97():200-9. PubMed ID: 24184688
[TBL] [Abstract][Full Text] [Related]
5. CD147, MMP9 expression and clinical significance of basal-like breast cancer.
Liu Y; Xin T; Jiang QY; Huang DY; Shen WX; Li L; Lv YJ; Jin YH; Song XW; Teng C
Med Oncol; 2013 Mar; 30(1):366. PubMed ID: 23292863
[TBL] [Abstract][Full Text] [Related]
6. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
Musumeci G; Castrogiovanni P; Barbagallo I; Tibullo D; Sanfilippo C; Nunnari G; Pellicanò GF; Pavone P; Caltabiano R; Di Marco R; Imbesi R; Di Rosa M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227596
[TBL] [Abstract][Full Text] [Related]
7. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
Liu X; Xu Q; Li Z; Xiong B
Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
[TBL] [Abstract][Full Text] [Related]
9. The expression of
Zhang X; Zheng Y; Liu X; Wang K; Zhao H; Yin Y; Yu Y
Ann Transl Med; 2022 Jan; 10(2):81. PubMed ID: 35282072
[TBL] [Abstract][Full Text] [Related]
10. Gene structure of the murine 2'-5'-oligoadenylate synthetase family.
Eskildsen S; Hartmann R; Kjeldgaard NO; Justesen J
Cell Mol Life Sci; 2002 Jul; 59(7):1212-22. PubMed ID: 12222967
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2'-5' oligoadenylate synthetase.
Rebouillat D; Marié I; Hovanessian AG
Eur J Biochem; 1998 Oct; 257(2):319-30. PubMed ID: 9826176
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
13. Clonality, Antigen Recognition, and Suppression of CD8
Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
[TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
15. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z
Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553
[TBL] [Abstract][Full Text] [Related]
16. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
Liu D; Vadgama J; Wu Y
Int J Biol Sci; 2021; 17(3):670-682. PubMed ID: 33767579
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
Kim S; Moon BI; Lim W; Park S; Cho MS; Sung SH
Clin Breast Cancer; 2018 Oct; 18(5):e1123-e1132. PubMed ID: 29754847
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic characteristics of breast cancer with basal-like immunophenotype].
Wu WX; Han WL; Zhang YP; Yu QX; Wen XW; Lu N; Tang ZY; Yuan LN; Zhang Y; Wang Z; Wang W; Yang HJ; Chen CP; Guo WL
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):743-8. PubMed ID: 19094708
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
Bai F; Jin Y; Zhang P; Chen H; Fu Y; Zhang M; Weng Z; Wu K
Aging (Albany NY); 2019 Nov; 11(21):9328-9347. PubMed ID: 31715586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
